Cardiometabolic & kidneyTrial design
Cleaner air for lower cardiometabolic risk: Protocol for a double-blind, randomized, sham-controlled trial of high efficiency particulate air (HEPA) filtration in adults with prediabetes
- randomized, double-blind, sham-controlled trial
- protocol
Study context
- Population
- Adults with prediabetes living in the New York City area
- Planned comparison
- treatment arm
- Primary endpoint
- continuous glucose monitoring metrics measured before and after HEPA air filtration
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Cleaner air for lower cardiometabolic risk: Protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes. Am Heart J. Published 14 August 2026. doi:10.1016/j.ahj.2026.107573
Summarised from the published abstract; every number is checked against it